Answers are grounded in this paper and cite their sources.
PNAs conjugated to carrier peptides have been employed for the targeting of miRNA precursor, with the aim to develop molecules able to interfere in the pre-miRNA processing. The capability of the molecules to bind pre-miRNA has been tested in vitro by fluorescence assayes on Thiazole Orange labeled molecules and in vivo, in K562 cells, evaluating the amount of miRNA produced after treatment of cells with two amounts of PNAs.
No takes yet. Share an insight, caveat, or question.
Avitabile et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: